Researchers compared the safety and cost of lowering asthma controller medications with maintaining current treatment levels in patients with controlled asthma.
The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.
New research has identified 3 distinct subsets of patients with severe asthma, a discovery that could lead to the development of new biologic therapies.
New research has identified 3 distinct subsets of patients with severe asthma, a discovery that could lead to the development of new biologic therapies.
Azithromycin may offer added benefit for patients with severe asthma who continue to experience exacerbations despite biologic therapy. Which outcome best reflects its impact on asthma control in this...
In this video, Payel Gupta, MD, explains a check list to help clinicians ensure their patients use an inhaler properly, including how and when to ask a patient to use the inhaler.
